Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Mar 18, 2022 9:56am
Let's hope imv's name does not come up
CTV: 'WHO pauses approval of Quebec's Medicago COVID-19 vaccine due to tobacco industry ties' Hello imv risk managament? did anyone look into this connection and evaluate downside? Board
...more
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Post by
Biotech010
on Mar 17, 2022 8:56am
Capitalize on DPX platform in 2022
On the webcast, which was great with lots of new info, the CEO mentioned right in the beginning, that IMV is going to capitalize on the DPX platform in 2022! This is the first time that the
...more
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Comment by
Biotech010
on Mar 14, 2022 3:33pm
RE:RE:prestigious oral presentation spot at AACR
IMV will present an abstract poster at the AACR conference featuring updated interim data with survivin vaccine candidate maveropepimut-S (MVP-S) plus KEYTRUDA with low dose cyclophosphamide (CPA
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Mar 11, 2022 11:32am
RE:prestigious oral presentation spot at AACR
Biotech,could you re-post Abbot's notes re the oral presentation as it did not come through on your post.
(5)
•••
Biotech010
X
View Profile
View Bullboard History
Post by
Biotech010
on Mar 11, 2022 6:50am
prestigious oral presentation spot at AACR
Nick Abbott at Wells Fargo put out a multi-company note this morning previewing presentations that his companies will make at the AACR conference next month. The AACR conference has replaced ASCO as
...more
(1)
•••
Jthom376
X
View Profile
View Bullboard History
Comment by
Jthom376
on Mar 08, 2022 8:20pm
RE:Updates
April..AACR though would think they would have EOY earnings.
(0)
•••
Lambom
X
View Profile
View Bullboard History
Post by
Lambom
on Mar 08, 2022 8:34am
Updates
Anyone know rough timing for scheduled next update? I think deep down theres some big news on the table but time will tell. I suppose now really is not a good time for them to do a major nr anyways
...more
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Comment by
antigua1987
on Feb 28, 2022 7:58pm
RE:Today
2hrs+. Lots of tech detail not so much intended for avg investor. But Graff and esp Kalos can talk in plain(ish) language. Key from Kalos: IMV has been doing good work - only needs new eyes to look at
...more
(0)
•••
Lambom
X
View Profile
View Bullboard History
Post by
Lambom
on Feb 24, 2022 8:37pm
Today
Did anyone listed today? Anything worthwhile?
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Feb 18, 2022 3:43pm
Did anyone catch Andy's utube vid before it disappeared?
Was there maybe a few weeks along with handful of other employee vids. Don't recall any obv faux pas. And eventho looked like he did it himself, it wasn't hostage quality. Must've messed
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Feb 17, 2022 10:09am
PR
IMV to Host a Webcast to Highlight its Immune-Educating DPX® Platform Download as PDF FEBRUARY 17, 2022 7:05AM EST Event will feature Michael Kalos, Ph.D., member of IMV
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Feb 11, 2022 11:07am
TRC’s Interview
LR,thanks for the link.This provides a good indication as to our current path forward with lots of examples. Let's hope the Feb. 24tr presentation provides more details as to what IMV's future
...more
(0)
•••
LR6852
X
View Profile
View Bullboard History
Comment by
LR6852
on Feb 11, 2022 9:53am
RE:Anyone else hoping MKalos brings it on Feb24?!
https://us5.campaign-archive.com/?e=__test_email__&u=d3a1417c9ff35564e0ddc31e9&id=c47da87871 This interview mentions what may be discussed at the Feb 24th event as well as other interesting
...more
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Feb 10, 2022 12:50pm
Anyone else hoping MKalos brings it on Feb24?!
It feels that exec team changes are producing, for now, a stronger company story: ceo, cso, vpIR trying to rebuild a foundation of confidence. And really expect heavyweights on BoD to shine IMVs light
...more
(1)
•••
TexasTea20
X
View Profile
View Bullboard History
Comment by
TexasTea20
on Feb 09, 2022 7:24pm
RE:RE:RE:RE:Shareprice
Still here. More shares than ever. Nothing to say. This just has to play out.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income